Stockreport

Xeris gains as Oppenheimer highlights drug technology [Seeking Alpha]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF Designed to deliver subcutaneous or intramuscular treatments instead of intravenous infusions, XeriSol and XeriJect allow for convenient, cost-effective drug storage, i [Read more]